things I've learnt over the last 14 months, page-2

First 2 Last

Share
Profile

Follow
col69

15,490 Posts.

5577

17/05/17

11:06

Post #: 24738264
Share

Originally posted by DerekT ↑

I've just old my final mesoblast shares in the last few weeks, having only held for around 14 months. Have made a 35% profit in that time, and I'm glad I'm out. Here's why:

1) There is something very unprofessional about the corporate updates and other communication this company provides. I'm not sure if it reflect dodginess or incompetence, but I'm not comfortable with them having my money
2) this company essentially has 1 product. They then package and brand this single product under multiple names and have somehow convinced some people that they have cures to multiple previously incurable diseases. Does this seem likely? Also, the TGA has just spoken its mind on the re-packaging of a single drug for multiple individual diseases (Ibuprofen).
3) Stem cells were supposed to be used to grow new tissue (e.g. for damaged hearts, damaged spinal cords). This hasn't happened. And it looks to me like stem cell companies are having to find uses for their very expensive products by testing them against every incurable disease out there. I am a doctor (in an unrelated field), but I did attend a half-day session on stem cells last year at a North American conference, and all the researchers there thought that clinical applications are at least a decade away. Of note and relevance to mesoblast, they used the GVHD product as an example of a failed drug (and failed company), and a paediatric cardiac surgeon from Boston presented on using stem cells for congenital heart disease and basically just present a series of negative studies. He was not optimistic. I don't think MSB is going to be curing any previously incurable diseases anytime soon.
4) As seen on this message board, people are either believers or non-believers, and tend to have very strong feelings either way. This doesn't happen for companies whose science is solid (e.g. CSL).
5) Financing and capital raising - the way this companies deals with investment banks and stock brokers is amateur, even by Australian standard. They have been taken for a ride, and there is no reason to think it won't happen again.

If I was interested in trading, I can see how it is possible to make money out of this company. I generally hold for the long term, and this company is not for me.

I'll continue to follow with interest. Good luck.

Expand

No disrespect, but I hope for our sake MSB is like your MOD call that you sold out of that hit an all time 12 month high in March this year

Sorry, but I can't agree with you that MSB is a one trick pony ?

Good luck with your future investments

MSB Price at posting: $2.33 Sentiment: Hold Disclosure: Held
14 Upvote

0 Great analysis

Reply

Top Stories

IVZ

Invictus banks US$5M from Zimbabwean investment fund in support of Cabora Bassa

BIO

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

AZL

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

PAM

PAM secures high-grade Chilean copper play in strong territory

BOE

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

There are more pages in this discussion • 24 more messages in this thread...

First 2 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.07		Change -0.055(4.89%)		Mkt cap ! $1.221B

Open	High	Low	Value	Volume
$1.14	$1.16	$1.06	$8.816M	8.055M

Buyers (Bids)

No.	Vol.	Price($)
1	280000	$1.07

Sellers (Offers)

Price($)	Vol.	No.
$1.07	2000	1

View Market Depth

No.	Vol.	Price($)
1	280000	1.065
5	149799	1.060
9	124023	1.055
14	191984	1.050
8	134232	1.045

Price($)	Vol.	No.
1.070	2000	1
1.075	19000	2
1.080	48905	3
1.085	28905	1
1.090	61845	5

Last trade - 16.10pm 29/07/2024 (20 minute delay)

MSB (ASX) Chart

things I've learnt over the last 14 months, page-2

Invictus banks US$5M from Zimbabwean investment fund in support of Cabora Bassa

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

PAM secures high-grade Chilean copper play in strong territory

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

things I've learnt over the last 14 months, page-2

Top Stories

Invictus banks US$5M from Zimbabwean investment fund in support of Cabora Bassa

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

PAM secures high-grade Chilean copper play in strong territory

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News